Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
194 A multicenter characterization of chronic toxicities following adjuvant anti-PD-1 therapy for high risk resected melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.